Internal Medicine, Hematology & Oncology · Clermont, FL
NPI
1043209950
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
2737 Citrus Tower Blvd
Clermont, FL, 34711
Phone (352) 242-1366
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.5M
439,427 services
Medicare patients, 2024
642
Average age 76
Drug cost, 2024
$10.1M
2,921 prescriptions
Company payments, 2025
$4,042
From 45 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gopal R Kunta was code J1756 (injection, iron sucrose, 1 mg), 222,300 times for 157 patients. In total Gopal R Kunta billed 439,427 services in 106 codes, and Medicare paid $3.5M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-09-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1756 Injection, iron sucrose, 1 mg | Office | 222,300 | 157 | $0.17 | $38K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 27,300 | 17 | $38.04 | $1.0M |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 12,260 | 27 | $6.34 | $78K |
| J0897 Injection, denosumab, 1 mg | Office | 9,900 | 51 | $17.99 | $178K |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 6,368 | 50 | $0.07 | $468 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 4,526 | 56 | $0.09 | $403 |
| 36415 Venipuncture Blood Collection | Office | 2,455 | 558 | $8.42 | $21K |
| 85025 Blood Count | Office | 2,442 | 548 | $7.61 | $19K |
| 99214 Office E&M - Established | Office | 1,447 | 470 | $97.06 | $140K |
| 96365 Intravenous Infusion, Hydration | Office | 1,325 | 188 | $47.05 | $62K |
| 96367 Intravenous Infusion, Hydration | Office | 890 | 95 | $21.63 | $19K |
| 96375 Injection Administration | Office | 722 | 51 | $11.86 | $8,566 |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 673 | 87 | $0.64 | $433 |
| 96372 Injection Administration | Office | 576 | 104 | $10.70 | $6,163 |
| 96413 Chemotherapy Administration | Office | 538 | 53 | $98.42 | $53K |
By year: 2022 $3.3M for 364,551 services; 2023 $3.1M for 478,224 services; 2024 $3.5M for 439,427 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 2,455 | 558 | $8.42 | $21K |
| 85025 Blood Count | 2,442 | 548 | $7.61 | $19K |
Medicare prescription drug claims, 2024
In 2024, the drug Gopal R Kunta prescribed most often to Medicare patients was Letrozole, with 187 prescriptions and refills. In total Gopal R Kunta wrote 2,921 Medicare prescriptions that cost $10.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 187 | 497 | 59 | $4,735 |
| Prednisone Generic | 162 | 171 | 31 | $797 |
| Abiraterone Acetate Generic | 142 | 142 | 22 | $152K |
| Eliquis Apixaban | 108 | 173 | 28 | $101K |
| Anastrozole Generic | 100 | 274 | 35 | $1,629 |
| Zoledronic Acid Generic | 99 | 110 | 16 | $6,885 |
| Dexamethasone Generic | 96 | 100 | 17 | $1,721 |
| Retacrit Epoetin Alfa-Epbx | 95 | 95 | 31 | $155K |
| Ondansetron Hcl Generic | 93 | 93 | 65 | $5,104 |
| Lupron Depot Leuprolide Acetate | 91 | 282 | 30 | $543K |
| Xtandi Enzalutamide | 87 | 87 | 12 | $1.2M |
| Pomalyst Pomalidomide | 86 | 86 | Under 11 | $1.8M |
| Darzalex Daratumumab | 72 | 72 | Under 11 | $794K |
| Fentanyl Generic | 63 | 63 | 17 | $6,985 |
| Hydroxyurea Generic | 61 | 140 | 16 | $2,755 |
Brand drugs: 1,069 claims; generic drugs: 1,852 claims; opioid claims: 154.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gopal R Kunta $4,042 ($3,453 in general payments such as food, travel and fees and $588 for research) from 45 companies. The largest payer was Merck Sharp & Dohme LLC with $754.
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC MRK | 9 | $754 |
| Regeneron Pharmaceuticals, Inc. REGN | 2 | $588 |
| BeOne Medicines USA, Inc. ONC | 3 | $210 |
| Novartis Pharmaceuticals Corporation NVS | 9 | $190 |
| Abbvie Inc. ABBV | 3 | $176 |
| ASD Specialty Healthcare, LLC | 2 | $174 |
| Gilead Sciences, Inc. GILD | 2 | $151 |
| Stemline Therapeutics Inc. | 2 | $143 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $142 |
| Pfizer Inc. PFE | 6 | $116 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.